… have similar tolerability and comparable compliance rates. The efficacy findings of this study
suggest that at least some hypertensive patients treated with valsartan have an apparently …

… endpoint was to evaluate the efficacy and safety of valsartan and fixed combination of valsartan
and HCTZ in wide populations of adult patients with mild to moderate AH. The secondary …

… Consistent with existing safety data (25), valsartan exhibited a favourable safety profile in
the present study, with a low incidence of study product-related AEs and discontinuation due to …

… assessed the superiority of sacubitril/valsartan 200 mg (97/103 … in patients with mild to
moderate essential hypertension uncontrolled with olmesartan 20 mg alone. A total of 376 patients …

… The current study focused on the long-term safety and tolerability of valsartan along with
the efficacy in paediatric patients aged 6 to 17 years with or without CKD. Most …

… safety issues. We aimed to summarize the available evidence regarding sacubitril-valsartan’s
safety and tolerability. … that sacubitril-valsartan was at least as safe and tolerable as the …

… compared with those of olmesartan are not well established in Japanese patients with …
efficacy and safety of sacubitril/valsartan in Japanese patients with mild to moderate essential …

… efficacy and safety of angiotensin receptor neprilysin inhibitor sacubitril/valsartan vs olmesartan
in Asian patients with mild-… The safety profile of sacubitril/valsartan reported in this study …

… AEs to date, either in patients with hypertension 14,15 or … safety and tolerability profile of
LCZ696 to valsartan and all of the coadministered free combinations of sacubitril and valsartan…

… In the 8-week dose-ranging study in Asian patients with hypertension, sacubitril/valsartan …
safety, tolerability and efficacy of sacubitril/valsartan in patients with essential hypertension. …